Knowledge Center
Article / Feb 01, 2015
The Time Has Come
Source:
PMPS, 2015, February, pp. 30 - 33
The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.
With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.
Related links
Also in the Knowledge Center
/ Oct 19, 2026
A dimensionless framework for hold-up mass prediction and scale transfer in continuous linear blending
Read more
Scientific Article
/ Oct 26, 2026
Streamlined development of continuous blending through integrated process understanding and predictive modeling
Read more
Scientific Article
/ Aug 04, 2026
Hovione: Accelerating Oral Drug Development Through Rapid Prototyping and Integrated Development Strategies
Read more
Scientific Article